Drug Resistance Updates: Volume 48 to Volume 53

Drug Resistance Updates (DRU) is a pivotal scientific journal delivering groundbreaking original research, enlightening commentary, and insightful expert reviews focusing on the crucial developments related to drug resistance in infectious diseases and cancer. It stands as a beacon of knowledge and innovation, addressing the urgent needs of overcoming drug resistance through novel drugs and therapeutic strategies. DRU is committed to providing a comprehensive platform to foster discussion, exploration, and knowledge dissemination in the intricate realm of drug resistance.

Multidisciplinary Scope:

DRU embraces a diverse array of disciplines including molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine. It ensures a holistic approach to understanding both the basic research and clinical aspects of drug resistance, making it a multidimensional resource for professionals from various scientific domains.

Content Types:

• Original Research Articles: DRU is a hub for novel and innovative research articles that contribute significantly to the scientific community’s understanding of drug resistance. These articles are peer-reviewed and are esteemed for their originality and impact.
• Commentary & Expert Reviews: The journal publishes enlightening commentaries and insightful reviews that explore and analyze significant developments in the field. These are authoritative pieces that offer deep insights into the complexities of drug resistance.
• Invited Reviews: Review articles in DRU are typically by invitation and are authored by eminent leaders in the field, ensuring the credibility, depth, and relevance of the content.

Clinical and Basic Research Integration:

DRU serves as a bridge between basic research and clinical aspects of drug resistance, offering a panoramic view of the challenges and breakthroughs in combating drug-resistant strains in both infectious diseases and cancer. This integration is crucial for fostering an enhanced understanding and developing effective strategies against drug resistance.

Encouragement for Submissions:

While the journal welcomes and encourages the submission of pioneering original research articles, review articles are predominantly composed by renowned experts in the field of drug resistance, contributing to the rich tapestry of knowledge and expertise contained within the journal.

Aims and Objectives:

The aim of Drug Resistance Updates is to be the cornerstone for scientific discourse and learning about the evolving challenges of drug resistance in infectious disease and cancer. It seeks to inspire research and discussions on novel strategies, drugs, and interventions to mitigate drug resistance, impacting the scientific community and beyond.

Conclusion:

In conclusion, Drug Resistance Updates is a comprehensive, multidisciplinary journal that stands at the forefront of scientific inquiry and innovation in the realm of drug resistance. It amalgamates diverse disciplines to offer profound insights into the advancements, challenges, and strategies in overcoming drug resistance in infectious diseases and cancer. DRU’s commitment to publishing original research, expert commentary, and reviews by leading professionals makes it an invaluable resource for those involved in the relentless pursuit of knowledge and solutions in the field of drug resistance.

Volume 48: January 2020

Volume 49: March 2020

Volume 50: May 2020

Volume 51: July 2020

Volume 52: September 2020

Volume 53: December 2020